Xu, Z., Zhang, M., Zhang, X., Han, H., Ye, W., Chen, Z., . . . Yan, X. (2025). Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathway. Renal Failure, 47(1), 1. https://doi.org/10.1080/0886022X.2025.2490202
Chicago Style (17th ed.) CitationXu, Zheming, et al. "Dihydromyricetin Protects Against Cisplatin-induced Renal Injury and Mitochondria-mediated Apoptosis via the EGFR/HSP27/STAT3 Signaling Pathway." Renal Failure 47, no. 1 (2025): 1. https://doi.org/10.1080/0886022X.2025.2490202.
MLA (9th ed.) CitationXu, Zheming, et al. "Dihydromyricetin Protects Against Cisplatin-induced Renal Injury and Mitochondria-mediated Apoptosis via the EGFR/HSP27/STAT3 Signaling Pathway." Renal Failure, vol. 47, no. 1, 2025, p. 1, https://doi.org/10.1080/0886022X.2025.2490202.